Banner by

A Lifeline in the Cord 

by Harshitha Gompa

The moment a child takes its first breath in the delivery room is nothing short of extraordinary. For a parent, every instinct, every hope, and every fear converges in that one breath. Who will this tiny life grow up to be? How can I protect them? Can I keep them safe? And, in just a single snip, the final tether to the womb that nurtured it for nine months is severed. A stream of blood, thick with life, flows out, often presented to parents as a once-in-a-lifetime lifeline for their newborn. In that moment, a parent holds not only their child, but the weight of a decision: to preserve or discard the umbilical cord — a biological safeguard for the fragile life now resting in their arms?  

Cord-blood banking is the process of collecting and freezing stem-cell-rich blood from a newborn’s umbilical cord or the mother’s placenta after birth for potential future medical treatments. Today, cord blood is used to treat or alleviate about 80 different diseases, including various blood disorders, cancers, genetic conditions, and immunodeficiencies. It has also made major advancements in treating conditions previously considered untreatable like cerebral palsy. For this reason, parents are often offered the option to store their child’s cord blood as a preventative measure against an uncertain future. However, while cord blood undeniably has real medical value, calling it a “miracle lifeline” and a once-in-a-lifetime opportunity often oversimplifies the feasibility and real-world practicality.   

Stem cells are special human cells that can self-renew indefinitely and play an important role in tissue maintenance and regeneration. Umbilical cord blood is a rich source of hematopoietic stem cells and is therefore used to regenerate blood and immune systems, helping treat cancers such as leukemia and lymphoma, as well as blood disorders like sickle cell anemia.. While cord blood is not the only source of stem cells, it has some unique advantages over other sources like adult bone marrow, fat, and blood . Cord blood is readily available at birth, its immune cells are more naïve and less likely to be rejected, and it can even be stored for future use. For some pediatric patients, a child’s own cord blood could be the only practical source of compatible stem cells, making it a crucial tool in life-saving treatments.  

Cord blood transplantation has saved thousands of lives; however, the likelihood that a child will actually need their own stored cord blood is extremely low. The vast majority of these transplants involve stem cells donated from another person rather than the patient’s own stored cord blood. According to Sue Armitage in 2016, over the past two decades, more than 35,000 unrelated cord blood units have been used worldwide for transplantation, compared with fewer than 1,000 autologous transplants using a patient’s own stored cord blood. One reason for this difference is that autologous cord blood may not be suitable for treating many genetic diseases or certain cancers. Because these conditions originate from mutations already present in the patient’s cells, the cord blood collected at birth may carry the same genetic abnormalities and therefore cannot be used as a treatment. This means that while cord blood banking holds scientific promise, the statistical probability that an individual child will require their own stored cord blood remains very small. 

When families consider cord blood banking, they typically have three main options: public donation, private cord blood banking, or hybrid banking. Public cord blood banks operate similarly to blood donation systems and are based on altruistic contributions free of cost. The unit is stored in a national or international registry where it may be used by any patient who is a suitable match. These donations help increase the diversity and availability of stem cell units for patients who require transplantation and may also support scientific research. In contrast, private cord blood banks, often referred to as family banks, store cord blood exclusively for potential use by the child or their relatives. Families pay an initial collection fee, often ranging between $1500 and $3000 followed by annual storage costs of $100 to $300 to maintain the sample, making private cord blood banking an expensive undertaking. Hybrid banks combine elements of both systems. Some hybrid banks allow families to store cord blood privately while also making a portion available to the public or a designated relative, attempting to balance personal security with broader societal benefit. 

Marketing practices often blur these distinctions, and expectant parents don’t usually receive sufficient information from healthcare providers, making the decision even more confusing. In 2022,noted by Waller Wise in Umbilical Cord Blood Banking: An Update for Childbirth Educators, “Many times, the medical advertised reasons for why a family should bank the umbilical cord blood are distorted. The advertisements are laced with promises of cures for diseases for which current therapies do not exist. In fact, as previously reported, the diseases may be in clinical trials, but not the actual treatment phase of care. The private banks can utilize this tactic because ‘the actual product or service offered is the banking of blood, not the predicted or hypothesized future treatments that may be mentioned in marketing’.” Understanding these distinctions is crucial for families to make informed decisions based on evidence rather than promotional claims. 

Parents face a profound choice at the time of their child’s birth—one that blends hope for their child’s future with uncertainty about the best path forward. Despite the medical promise of cord blood, autologous cord blood is rarely used in transplantation. Public donation can benefit others and support medical research, while private banking remains costly. It is generally recommended by the American Academy of Pediatrics when a known condition in a family member may be treated with stem cell transplantation. There is no single “right” choice, but being well-informed is essential. Understanding the science and the marketing around cord blood enables families to make decisions grounded in evidence and suited to their own needs. Cord blood can be a lifeline—but it is not the same lifeline for every child. What matters is not just the hope it carries, but the knowledge that guides the choice—making the decision to bank cord blood as unique as the life it comes from.